Attached files
file | filename |
---|---|
EX-99.1 - China Botanic Pharmaceutical | v204449_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): November 29, 2010
CHINA
BOTANIC PHARMACEUTICAL INC.
(Exact
name of Registrant as Specified in its Charter)
Nevada
|
0-24512
|
88-1273503
|
||
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
No.
281, Taiping Road, Taiping District
Harbin,
Heilongjiang Province, 150050
(Address
of Principal Executive Offices)
Registrant’s
telephone number, including area code: 86-451-5762-0378
N/A
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 8.01
Other Events.
On
November 29, 2010, Renhuang Pharmaceuticals, Inc. issued a press release
announcing that its name change to “China Botanic Pharmaceutical Inc.” had
become effective.
A copy of
the press release is attached hereto as Exhibit 99.1 and incorporated by
reference herein.
Item 9.01(d).
Financial Statements and Exhibits.
Exhibit
No.
|
Description
|
|
99.1
|
Press
Release dated November 29, 2010
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
RENHUANG
PHARMACEUTICALS, INC.
|
|||
Date:
December 2, 2010
|
By:
|
/s/
Shaoming Li
|
|
Shaoming
Li
|
|||
Chief
Executive Officer
|
|||
EXHIBIT
INDEX
Exhibit
No.
|
Description
|
|
99.1
|
Press
Release dated November 29, 2010
|